US-based biopharmaceutical company Allergan has completed the acquisition of LifeCell, the regenerative medicine unit of Acelity.

Acelity’s regenerative medicines business and dermal matrix products are added to Allergan’s portfolio as a result of the acquisition.

Biopharmaceutical services provider Parexel International is set to acquire The Medical Affairs Company (TMAC), a full-service contract medical services provider founded in 2007 and based in the US.

Parexel intends to gain new and distinct medical affairs outsourcing capabilities through the acquisition.